Biocon Biologics' Drug Substance Facility in Bengaluru Classified as Voluntary Action Indicated

"The U.S. Food and Drug Administration (FDA) CDER-OC, Office of Manufacturing Quality, has classified Biocon Biologics' Drug Substance Facility at Biocon Campus, located in Bengaluru, Karnataka, as Voluntary Action Indicated (VAI).

This relates to the inspection conducted by the agency between August 26 to September 3, 2025, and pertains to the manufacture and supply of Human Recombinant Insulin (rh- Insulin) and Biosimilar Pegfilgrastim Drug Substance to the United States.

Biocon Biologicsremains committed to globalstandards of Quality and Compliance. - Company Spokesperson.

Shares of Biocon Limited was last trading in BSE at Rs. 398.55 as compared to the previous close of Rs. 393.15. The total number of shares traded during the day was 64239 in over 1543 trades.

The stock hit an intraday high of Rs. 400.00 and intraday low of 393.20. The net turnover during the day was Rs. 25510261.00.

Source : Equity Bulls

Keywords

Biocon INE376G01013 Biotechnology BioconBiologics DrugSubstanceFacility Bengaluru VAI